183 related articles for article (PubMed ID: 1699006)
1. [Treatment of aplastic anemia with KRN8601 (rhG-CSF)].
Kojima S; Matsuyama T; Miyazaki T; Sakurada K; Shike S; Okino E; Akabane T; Nakahata T; Okuni M; Mugishima H
Rinsho Ketsueki; 1990 Jul; 31(7):929-36. PubMed ID: 1699006
[TBL] [Abstract][Full Text] [Related]
2. [Clinical effect of recombinant human granulocyte colony-stimulating factor on aplastic anemia].
Asano S; Hirashima K; Yoshida Y; Takaku F; Miyazaki T; Omine M; Furusawa S; Abe T; Mori M; Arimori S
Rinsho Ketsueki; 1990 Sep; 31(9):1456-62. PubMed ID: 1701008
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study of rhG-CSF (KRN8601) in patients with myelodysplastic syndrome].
Toyama K; Ohyashiki J; Takaku F; Kobayashi Y; Miyazono K; Miura Y; Sakamoto S; Mizoguchi H; Hoshino S; Urabe A
Rinsho Ketsueki; 1990 Jul; 31(7):937-45. PubMed ID: 1699007
[TBL] [Abstract][Full Text] [Related]
4. [A phase III trial of subcutaneous administration of rhG-CSF in aplastic anemia].
Yoshida Y; Okuma M; Suzuki T; Takahashi T; Nakagawa M; Kashima K; Abe T; Sonoda Y; Fujii H; Haruyama H
Rinsho Ketsueki; 1994 Nov; 35(11):1282-8. PubMed ID: 7529841
[TBL] [Abstract][Full Text] [Related]
5. Multilineage response in aplastic anemia patients following long-term administration of filgrastim (recombinant human granulocyte colony stimulating factor).
Sonoda Y; Ohno Y; Fujii H; Takahashi T; Nakayama S; Haruyama H; Nasu K; Shimazaki C; Hara H; Kanamaru A
Stem Cells; 1993 Nov; 11(6):543-54. PubMed ID: 7509223
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.
Shimazaki C; Uchiyama H; Fujita N; Araki S; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Haruyama H
Exp Hematol; 1995 Dec; 23(14):1497-502. PubMed ID: 8542937
[TBL] [Abstract][Full Text] [Related]
7. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
Fukutani H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Shinagawa K; Tabata M; Hirano A; Mizunuma N
Gan To Kagaku Ryoho; 1989 May; 16(5):2005-12. PubMed ID: 2471461
[TBL] [Abstract][Full Text] [Related]
8. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
Teshima H; Ishikawa J; Kitayama H; Yamagami T; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
Exp Hematol; 1989 Sep; 17(8):853-8. PubMed ID: 2475358
[TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of effects of KRN8601 (rhG-CSF) on neutropenia].
Nakahata T; Akabane T; Miura A; Tada K; Uzuka Y; Hayashi T; Shibata A; Shiko S; Okuni M; Urabe A
Rinsho Ketsueki; 1992 Feb; 33(2):123-32. PubMed ID: 1378911
[TBL] [Abstract][Full Text] [Related]
11. [A phase III trial of subcutaneous administration of rhG-CSF in the myelodysplastic syndromes].
Yoshida Y; Okuma M; Suzuki T; Takahashi T; Nakagawa M; Kashima K; Abe T; Sonoda Y; Fujii H; Haruyama H
Rinsho Ketsueki; 1994 Nov; 35(11):1289-96. PubMed ID: 7529842
[TBL] [Abstract][Full Text] [Related]
12. Treatment of aplastic anemia in children with recombinant human granulocyte colony-stimulating factor.
Kojima S; Fukuda M; Miyajima Y; Matsuyama T; Horibe K
Blood; 1991 Mar; 77(5):937-41. PubMed ID: 1995101
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor.
Vadhan-Raj S; Buescher S; Broxmeyer HE; LeMaistre A; Lepe-Zuniga JL; Ventura G; Jeha S; Horwitz LJ; Trujillo JM; Gillis S
N Engl J Med; 1988 Dec; 319(25):1628-34. PubMed ID: 3059191
[TBL] [Abstract][Full Text] [Related]
14. A new bioassay for human granulocyte colony-stimulating factor (hG-CSF) using murine myeloblastic NFS-60 cells as targets and estimation of its levels in sera from normal healthy persons and patients with infectious and hematological disorders.
Shirafuji N; Asano S; Matsuda S; Watari K; Takaku F; Nagata S
Exp Hematol; 1989 Feb; 17(2):116-9. PubMed ID: 2463930
[TBL] [Abstract][Full Text] [Related]
15. A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.
Rifkin RM; Hersh EM; Salmon SE
Behring Inst Mitt; 1988 Aug; (83):125-33. PubMed ID: 3071327
[TBL] [Abstract][Full Text] [Related]
16. Clinical effect of granulocyte colony-stimulating factor on neutrophils and leukemic cells in myelogenous leukemia: analysis.
Ishikawa J; Yoshimura M; Matsunashi T; Tominaga N; Teshima H; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
Jpn J Clin Oncol; 1991 Jun; 21(3):169-75. PubMed ID: 1719259
[TBL] [Abstract][Full Text] [Related]
17. Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia.
Kurzrock R; Talpaz M; Gutterman JU
Am J Med; 1992 Jul; 93(1):41-8. PubMed ID: 1626572
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in autologous bone marrow transplantation].
Takahashi S; Asano S; Masaoka T; Takaku F; Niitsu Y; Shibuya A; Saito H; Sekine I; Sanpi K; Hanada R
Rinsho Ketsueki; 1991 Mar; 32(3):221-6. PubMed ID: 1710295
[TBL] [Abstract][Full Text] [Related]
19. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of GM-CSF in patients with aplastic anemia and myelodysplastic syndrome. (CSF39-300 Study Group)].
Kitamura K; Asano S; Mizoguchi H; Takaku F
Rinsho Ketsueki; 1993 Dec; 34(12):1540-9. PubMed ID: 8295327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]